Dataa | Follow-up | Treatmentb | p-value*** | |
---|---|---|---|---|
Ginger extract | Loratadine | |||
Minimal cross section area of right nose (cm2) | Week 0 | 0.32 (0.14) | 0.31 (0.14) | 0.661 |
Week 3 | 0.34 (0.15) | 0.32 (0.14) | 0.771 | |
Week 6 | 0.37 (0.15) | 0.32 (0.14) | 0.120 | |
Minimal cross section area of left nose (cm2) | Week 0 | 0.34 (0.16) | 0.31 (0.18) | 0.378 |
Week 3 | 0.36 (0.14) | 0.31 (0.13) | 0.164 | |
Week 6 | 0.35 (0.10) | 0.31 (0.13) | 0.160 | |
Volume estimates of the right nasal cavity (cm3) | Week 0 | 3.83 (0.98) | 3.62 (1.04) | 0.365 |
Week 3 | 3.95 (1.18) | 3.84 (1.21) | 0.685 | |
Week 6 | 4.38 (1.42) † | 3.63 (1.20) | 0.018* | |
Volume estimates of the left nasal cavity (cm3) | Week 0 | 3.95 (1.11) | 3.53 (1.16) | 0.103 |
Week 3 | 4.28 (1.28) | 3.65 (0.87) | 0.014* | |
Week 6 | 4.25 (0.99) † | 3.67 (1.15) | 0.027* | |
Distance from the nostril of right nose (cm) | Week 0 | 2.11 (0.31) | 2.22 (0.25) | 0.091 |
Week 3 | 2.15 (0.30) | 2.16 (0.30) | 0.828 | |
Week 6 | 2.19 (0.21) | 2.16 (0.32) | 0.607 | |
Distance from the nostril of left nose (cm) | Week 0 | 2.11 (0.28) | 2.27 (0.43) | 0.068 |
Week 3 | 2.11 (0.29) | 2.20 (0.32) | 0.245 | |
Week 6 | 2.07 (0.35) | 2.26 (0.29) | 0.011* |